BioStone Animal Health Launches FMDV Type O and Asia1 Antibody cELISA Test Kits
DALLAS-FORT WORTH, TX — October 22, 2021 — BioStone Animal Health is proud to announce the launch of the AsurDxTM FMDV Type O Antibody Competitive ELISA (cELISA) Test kit and AsurDxTM FMDV Type Asia1 Antibody Competitive ELISA (cELISA) Test kit for the detection of antibodies specific to foot and mouth disease virus (FMDV) serotype O and Asia1 in bovine, ovine, caprine or swine-origin respectively.
Foot and mouth disease (FMD) is caused by the FMD virus (FMDV), which is a member of the genus Aphthovirus and the family Picornaviridae. FMD is one of the most highly contagious and economically devastating diseases of cloven-hoofed animals, and it severely constrains the international trade of animals and animal products.
Combined with test kits launched previously, we now have FMDV Type A, O, and Asia1 Antibody cELISA kits for vaccinated sample antibody titer testing and FMDV DIVA blocking ELISA kit for the infected samples testing in multispecies. These testing kits could provide a simple, rapid, sensitive, and cost-effective competitive enzyme-based immunoassay (cELISA) screening method for most of the FMDV serotypes.
About BioStone Animal Health — BioStone Animal Health is a Dallas, TX-based biotechnology company that provides innovative solutions for animal health. BioStone Animal Health works together with our worldwide partners to offer a portfolio of animal disease diagnostic products as well as test kits and reagents for vaccine testing that enables performing a rapid evaluation of the efficacies, stability, consistency, and potency of common animal vaccines. By making these test kits available to the international community, BioStone strives to promote and participate in global animal health initiatives actively. For more information about BioStone Animal Health, visit: www.biostoneah.com